Redefining Alopecia Areata Management with Baricitinib Transition from Clinical Trials to RWE in Plaque Psoriasis

Overview

Updates about Psoriasis and Alopecia Areata management

This Activity for

• Resident / Fellow
• Physician
• Pharmacy

What I will learn?

Communicate Baricitinib and Ixekizumab value proposition in a speaker program setting to communicate what the product may mean to people living with Alopecia Areata and Psoriasis Diseases

About Organizer

• Virtual Medical Academy

Additional items to the activity

Optional Details	Type	Fee
Redefining Alopecia Areata Management with Baricitinib Transition from Clinical Trials to RWE in Plaque Psoriasis Certificate	Certificate	Free

VAT 15% Included